Before the Bell Rings: Tough Questions Surround the 1Doc IPO

 

1Doc IPO Under the Spotlight: NukeMan Raises Tough Questions That Regulators Should Answer




I've been following the so-called "Corporate Mafia" story for years. If you've been around the Malaysian blogosphere long enough, one name keeps popping up: NukeMan.

Love him or hate him, you can't accuse the man of disappearing when the heat gets turned up.

Long before bigger newsrooms started paying attention to questions about corporate governance, IPOs, and the cozy relationships between boardrooms, financiers, and political circles, NukeMan was already firing away from his little corner of the internet. Sometimes people dismissed him. Sometimes they laughed. But one thing I'll give him: he has never really changed his tune.

Now he's turned his attention to 1Doc International Bhd.



And no, his latest argument isn't simply about who owns the company or which well-connected personalities may or may not be associated with it. His concern goes deeper. He believes the IPO deserves closer public scrutiny because he sees several questions that, in his view, have yet to be answered convincingly.

Whether he's right or wrong is another matter.

One point he raises is what he describes as relatively weak institutional interest. Based on what he says are his own sources, he questions why major institutional investors, bankers, or underwriters did not appear eager to absorb a larger portion of the institutional offering.

That naturally leads to one simple question.

Why?

Maybe there's a perfectly ordinary explanation. Markets can be cautious. Investors can disagree. Timing matters. None of that automatically points to a problem.

But as a journalist, I've learned something over the years: asking questions isn't the crime. Refusing to answer them is where confidence starts to crack.

NukeMan also highlights the IPO structure itself.

According to the prospectus, around 238.98 million shares are being offered through existing shareholders selling their holdings, while 341.40 million new shares are being issued by the company.

There's nothing inherently improper about an Offer for Sale. Existing shareholders sell shares in IPOs for many legitimate reasons—portfolio diversification, realizing investments, or other financial planning.

Still, NukeMan argues that retail investors should understand why insiders are reducing their stakes at the point of listing and make their own judgment after reviewing the available information.




That's a fair question for any investor to ask, regardless of the company involved.

He also points to historical Bursa Malaysia data suggesting that IPOs with relatively large Offer for Sale components have, in some cases, underperformed after listing. Of course, history is not destiny. Past market performance doesn't predict the future, and every IPO stands on its own merits. But historical context is still part of the bigger picture investors often consider.

One detail that caught my attention is this.

Despite everything NukeMan has written over the years about what he calls the "Corporate Mafia," he has also publicly stated that he does not believe the Malaysian Anti-Corruption Commission (MACC), particularly its former Chief Commissioner Tan Sri Azam Baki, is involved in what he describes. That sets his position apart from many sweeping claims circulating on social media.

At the end of the day, allegations remain allegations until they're supported by evidence.

Facts don't fear daylight.

If NukeMan's concerns are misplaced, then transparency is the quickest way to restore confidence. If there are genuine regulatory issues, they deserve to be examined through the proper channels—not debated endlessly on Facebook or whispered in investment circles.

That's why I believe it would be in the public interest for Bursa Malaysia and the Securities Commission Malaysia (SC) to review the questions that have been raised, to the extent they fall within their regulatory responsibilities. A clear assessment would either reinforce confidence in the listing process or identify matters requiring further attention.

Capital markets don't survive on glossy prospectuses alone.

They survive on trust.

And trust isn't built by asking people to stay quiet. Trust is built when difficult questions are met with credible answers.

As the old Malay proverb reminds us, "Berani kerana benar, takut kerana salah."

If everything is indeed above board, then transparency should never be the enemy.

P.S. One last thing. NukeMan isn't done yet. His fifth and latest article shifts the spotlight to the so-called "Beauty Mafia."






Comments